ACE2 and infection: In those with previous infection, there was consistent evidence of higher neutralization activity against variants of concern using the RBD binding inhibition to ACE2 assay (Figure S5D), suggesting that “hybrid immunity” from previous infection plus vaccination gives the strongest cross-reactive neutralization.